Clinical Trials Directory

Trials / Completed

CompletedNCT02034526

Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome.

A Randomised Controlled Trial of Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome and Dual Chamber Pacemaker.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
540 (actual)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation (AF) is prevalent in patients with sick sinus syndrome (SSS) and associated with an increased risk of stroke and death. Within the first two years after pacemaker implantation almost half of the patients are diagnosed with AF. Studies have indicated that an increased amount of stimulation from the pacemaker in the atria is associated with an increased amount of AF. The aim of the present study is to test the hypothesis that a reduction of stimulation from the pacemaker in the atria, and reducing the minimal heart rate, increases the time to AF.

Conditions

Interventions

TypeNameDescription
DEVICEDDDR-60DDDR, lower pacing rate 60 bpm, RR activated (low-moderate)
DEVICEDDD-40DDD, lower pacing rate 40 bpm, RR function off

Timeline

Start date
2014-05-01
Primary completion
2023-03-31
Completion
2023-03-31
First posted
2014-01-13
Last updated
2024-02-08

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02034526. Inclusion in this directory is not an endorsement.